Multicystic Interstitial Lung Disease Due to a Novel Biallelic C‐C Chemokine Receptor Type 2 Variant
Pediatric Pulmonology · 2025
DOI: 10.1002/ppul.71135 ↗At a glance
Fallbericht in Pediatric Pulmonology, 2025. Written by Moritz Herkner and 16 co-authors. Institution: Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. Major MEDLINE topics: Receptors, CCR2, Lung Diseases, Interstitial. Cited 1 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY 4.0). Funded by: M. S. is participant of the BIH-Charité Clinician Scientist Program funded by the Charité-Universitätsmedizin Berlin and the BIH. M. S. was supported by the Ge….
Abstract (original language)
Objective
We are presenting two individuals with biallelic C‐C chemokine receptor type 2 (CCR2) deficiency carrying the novel c.644C>T p.L215P variant, who presented with chronic respiratory symptoms during infancy and developed multiple diffuse cystic lesions during childhood.
Methods
The patients were diagnosed by means of whole exome sequencing and functional validation of the variant was performed in primary patient cells.
Results
While size and extent of the cysts were stable over years, progressive lung function decline was noted in adolescence and adulthood respectively. The CCR2 p.L215P variant was found to be loss‐of‐expression and patient monocytes displayed a migration defect upon stimulation with the CCR2 ligand C‐C motif ligand 2 (CCL2).
Conclusion
With a follow‐up of up to 25 years, this report expands our understanding of lung disease in CCR2 deficiency and offers another monogenic cause of cystic lung disease. Early genetic diagnosis of affected individuals might allow potentially curative treatment by haematopoietic stem cell transplantation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
- Department of Pediatric Respiratory Medicine, Immunology and Intensive Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
- German Center for Lung Research (DZL) Associated Partner Site, Berlin, Germany.
- Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany.
- Institute of Pathology, University of Würzburg, Würzburg, Germany.
- Department of Pediatrics, Division of Pulmonology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
ORCID profiles: Simon Y Graeber, Nagehan Emiralioglu, Mirjam Stahl, Matthias Griese, Florian Gothe
Funding
- M. S. is participant of the BIH-Charité Clinician Scientist Program funded by the Charité-Universitätsmedizin Berlin and the BIH. M. S. was supported by the Ge…
Cite
APA
Herkner, M., Rapp, C., Graeber, S. Y., Marx, C., Rambuscheck, C., Reu-Hofer, S., Emiralioglu, N., Kiper, N., Gilea, A. I., Notaroberto, I., Baruffini, E., Temmesfeld-Wollbrück, B., Klein, C., Wen, H., Stahl, M., Griese, M., & Gothe, F. (2025). Multicystic Interstitial Lung Disease Due to a Novel Biallelic C‐C Chemokine Receptor Type 2 Variant. Pediatric Pulmonology. https://doi.org/10.1002/ppul.71135
Vancouver
Herkner M, Rapp C, Graeber SY, Marx C, Rambuscheck C, Reu-Hofer S, et al. Multicystic Interstitial Lung Disease Due to a Novel Biallelic C‐C Chemokine Receptor Type 2 Variant. Pediatric Pulmonology. 2025. doi:10.1002/ppul.71135
BibTeX
@article{Herkner2025,
author = {Herkner, Moritz and Rapp, Christina and Graeber, Simon Y and Marx, Charlotte and Rambuscheck, Carlotta and Reu-Hofer, Simone and Emiralioglu, Nagehan and Kiper, Nural and Gilea, Alexandru I and Notaroberto, Ilenia and Baruffini, Enrico and Temmesfeld-Wollbrück, Bettina and Klein, Christoph and Wen, Han and Stahl, Mirjam and Griese, Matthias and Gothe, Florian},
title = {Multicystic Interstitial Lung Disease Due to a Novel Biallelic C‐C Chemokine Receptor Type 2 Variant},
journal = {Pediatric Pulmonology},
year = {2025},
doi = {10.1002/ppul.71135}
}
EUVIMED